TECH OFFER

A Modified Antigenic Hypothetical Lipoprotein For The Diagnosis Or Preventation Of Meliodosis

TECHNOLOGY OVERVIEW

The present invention relates to an isolated antigenic polypeptide for use in detecting or preventing melioidosis, encoded by a truncated polynucleotide fragment having a nucleotide sequence as set forth in SEQ ID NO: 1 or the complementary sequence thereof. The present invention also relates to a recombinant plasmid comprising a cloning vector and the truncated polynucleotide; and a transformant harbouring a recombinant plasmid comprising the truncated polynucleotide fragment, wherein the recombinant plasmid being expressible in a bacterial host to yield a truncated antigenic polypeptide. The truncated protein is confirmed antigenic since it can be recognised by melioidosis patients’ serum. The most illustrative drawing

Mega - Trends

Chemicals and Materials, Healthcare

Technology Readiness Level (TRL)

TRL 3

Patent Number

MY-170434-A

Get the technology fact sheet here:

Contact person for this offer:

ChM Dr. Lee Ching Shya, PhD (Dual), RTTP

Technology Transfer Manager

Email: leecs@um.edu.my

Tel: +603-7967-7351/ 013-2250151

MAKE AN ENQUIRY

press to zoom

press to zoom
1/1

MORE INFORMATION

You have a question to know about technologies or cooperations? 
Please Contact Us:

+603 - 7967 7351 / 013-2250151